Tumor markers are substances that are produced by cancer or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. Most tumor markers are made by normal cells as well as by cancer cells; however, they are produced at much higher levels in cancerous conditions. These substances can be found in the blood, urine, stool, tumor tissue, or other tissues or bodily fluids of some patients with cancer. Most tumor markers are proteins. However, more recently, patterns of gene expression and changes to DNA have also begun to be used as tumor markers.

Human Tumor marker DR-70 for lung cancer (DR-70TM) ELISA Kit employs a two-site sandwich ELISA to quantitate DR-70TM in samples. An antibody specific for DR-70TM has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and anyDR-70TM present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for DR-70TM is added to the wells. After washing, Streptavidin conjugated Horseradish Peroxidase (HRP) is added to the wells. Following a wash to remove any unbound avidin-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of DR-70TM bound in the initial step. The color development is stopped and the intensity of the color is measured.

Human Tumor marker DR-70 for lung cancer (DR-70TM) ELISA Kit listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Find more details at http://www.abbkine.com/product/human-tumor-marker-dr-70-for-lung-cancer-dr-70tm-elisa-kit-kte62601/

Abbkine Scientific Co., Ltd. was founded by a number of scientists and marketing experts in the field of life science in California in 2012. With growing demands from Asia Pacific, it move its headquarters to China. Combining cutting edge technology from United States with China's manufacturing engineering and cost advantages, we aim to provide innovative, high quality assay kits, recombinant proteins, antibodies and other research tools to accelerate life science fundamental research, drug discovery, etc.